Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers

Cancer

Volumn 119, Issue 14, 2013, Pages 2593-2601

  Gan, Samuel J ^a,b   Dahlstrom, Kristina R ^a   Peck, Brandon W ^a,c   Caywood, Wes ^a,d   Li, Guojun ^a   Wei, Qingyi ^a   Zafereo, Mark E ^a   Sturgis, Erich M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

head and neck neoplasms; human papillomavirus; laryngeal cancer; oral cancer; oropharyngeal cancer; second primary malignancy; smoking

Indexed keywords

ADULT; AGE; ARTICLE; BLADDER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; ESOPHAGUS; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CANCER; LUNG; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND CANCER; SMOKING; UNITED STATES; WART VIRUS;

HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS; LARYNGEAL CANCER; ORAL CANCER; OROPHARYNGEAL CANCER; SECOND PRIMARY MALIGNANCY; SMOKING;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; OROPHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION; SMOKING;

EID: 84879670380     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28107     Document Type: Article

References (31)

1. Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I,. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. 2011; 29: 739-746.
2. Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK,. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011; 29: 3503-3509.
3. Sturgis EM, Miller RH,. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol. 1995; 104: 946-954.
4. Do KA, Johnson MM, Lee JJ, et al. Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer. 2004; 101: 2837-2842.
5. Bosetti C, Scelo G, Chuang SC, et al. High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries. Int J Cancer. 2011; 129: 173-179.
6. Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J,. Second neoplasm in patients with head and neck cancer. Head Neck. 1999; 21: 204-210.
7. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP,. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005; 114: 806-816.
8. Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP,. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol. 2001; 19: 1358-1362.
9. Bhattacharyya N, Nayak VK,. Survival outcomes for second primary head and neck cancer: a matched analysis. Otolaryngol Head Neck Surg. 2005; 132: 63-68.
10. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612-619.
11. Sturgis EM, Ang KK,. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Canc Netw. 2011; 9: 665-673.
12. Sturgis EM, Cinciripini PM,. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007; 110: 1429-1435.
13. Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009; 18: 541-550.
14. Pytynia KB, Grant JR, Etzel CJ, Roberts DB, Wei Q, Sturgis EM,. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol. 2004; 22: 3981-3988.
15. Day GL, Blot WJ, Shore RE, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst. 1994; 86: 131-137.
16. Morris LG, Sikora AG, Hayes RB, Patel SG, Ganly I,. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control. 2011; 22: 671-679.
17. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92: 709-720.
18. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363: 24-35.
19. Huang SH, Perez-Ordonez B, Liu FF, et al. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys. 2012; 82: 276-283.
20. Warren S, Gates O,. Multiple primary malignant tumors. A survey of the literature and a statistical study. Am J Cancer. 1932; 16: 1358-1414.
21. Hiyama T, Sato T, Yoshino K, Tsukuma H, Hanai A, Fujimoto I,. Second primary cancer following laryngeal cancer with special reference to smoking habits. Jpn J Cancer Res. 1992; 83: 334-339.
22. Lubin JH, Purdue M, Kelsey K, et al. Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol. 2009; 170: 937-947.
23. Tomek MS, McGuirt WF,. Second head and neck cancers and tobacco usage. Am J Otolaryngol. 2003; 24: 24-27.
24. Moore C,. Cigarette smoking and cancer of the mouth, pharynx, and larynx. A continuing study. JAMA. 1971; 218: 553-558.
25. Silverman S, Gorsky M, Greenspan D,. Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancers. J Am Dent Assoc. 1983; 106: 33-35.
26. Castigliano SG,. Influence of continued smoking on the incidence of second primary cancers involving mouth, pharynx, and larynx. J Am Dent Assoc. 1968; 77: 580-585.
27. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR,. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995; 75: 1343-1353.
28. Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008; 123: 2390-2396.
29. Slaughter DP, Southwick HW, Smejkal W,. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953; 6: 963-968.
30. Sikora AG, Morris LG, Sturgis EM,. Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men. Arch Otolaryngol Head Neck Surg. 2009; 135: 402-405.
31. Peck BW, Dahlstrom KR, Gan SJ, et al. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers [published online ahead of print June 19, 2012]. Head Neck. 2012.